Alfresa Holdings Corporation (ALFRY)

OTCMKTS · Delayed Price · Currency is USD

13.80

-0.60 (-4.17%)

At close: May 28, 2026

-13.70% (1Y)

Market Cap	2.45B -0.2%
Revenue (ttm)	19.52B +4.8%
Net Income	262.55M +52.4%
EPS	1.44 +55.6%
Shares Out	n/a
PE Ratio	9.32
Forward PE	n/a
Dividend	0.44 (3.20%)
Ex-Dividend Date	Mar 30, 2026

Volume	146
Open	13.80
Previous Close	14.40
Day's Range	13.80 - 13.80
52-Week Range	11.39 - 16.81
Beta	-0.16
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 5, 2026

About Alfresa Holdings

Alfresa Holdings Corporation, through its subsidiaries, engages in the manufacture, wholesale, marketing, and import/export of pharmaceuticals, diagnostic reagents, and medical devices/equipment in Japan and internationally. It is also involved in the operation of dispensing pharmacies and conducting related businesses; ethical pharmaceuticals wholesaling business; self-medication products wholesaling business; and other medical-related businesses. In addition, the company manufactures and markets active pharmaceutical ingredients; contract dis... [Read more]

Industry Medical Distribution

Sector Healthcare

Founded 2003

Employees 12,452

Stock Exchange OTCMKTS

Ticker Symbol ALFRY

Financial Performance

In fiscal year 2026, Alfresa Holdings's revenue was 3.10 trillion, an increase of 4.83% compared to the previous year's 2.96 trillion. Earnings were 41.75 billion, an increase of 52.42%.

Financial numbers in JPY Financial Statements